Skip to main content

McWherter Charles's Form 4 filing

CymaBay Therapeutics, Inc. (CBAY) · filed Sep 19, 2023

Accession no.
0001062993-23-018280
Filed
Sep 19, 2023
Trade date
Sep 18, 2023
Filing delay
1 day
Rule 10b5-1 plan
Not checked

This filing lists 2 non-derivative transactions and 5 derivative transactions. Open-market sales total $352.7K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
McWherter CharlesCIK 0001588862Officer (President of R&D)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 18, 2023Common StockMOption exerciseAcquired+21,746$5.00+$108,73036,746Direct
Sep 18, 2023Common StockSSaleDisposed−21,746$16.22−$352,720.1215,000Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 18, 2023Common StockMOption exerciseDisposed−10,404$0.00$010,401Direct
Sep 18, 2023Common StockMOption exerciseDisposed−708$0.00$02,120Direct
Sep 18, 2023Common StockMOption exerciseDisposed−236$0.00$0706Direct
Sep 18, 2023Common StockMOption exerciseDisposed−3,892$0.00$011,674Direct
Sep 18, 2023Common StockMOption exerciseDisposed−6,506$0.00$019,516Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)